Last reviewed · How we verify
Zoliflodacin Patheon — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Zoliflodacin Patheon (Zoliflodacin Patheon) — Global Antibiotics Research and Development Partnership.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Zoliflodacin Patheon TARGET | Zoliflodacin Patheon | Global Antibiotics Research and Development Partnership | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Zoliflodacin Patheon CI watch — RSS
- Zoliflodacin Patheon CI watch — Atom
- Zoliflodacin Patheon CI watch — JSON
- Zoliflodacin Patheon alone — RSS
Cite this brief
Drug Landscape (2026). Zoliflodacin Patheon — Competitive Intelligence Brief. https://druglandscape.com/ci/zoliflodacin-patheon. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab